AP
AGN

Alydar Partners’s Allergan plc AGN Stock Holding History

Alydar Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$6.25M Sell
21,000
-84,947
-80% -$24.2M 3.39% 6
2014
Q4 		$27.3M Buy
105,947
+15,947
+18% +$3.99M 4.31% 3
2014
Q3 		$21.7M Sell
90,000
-170,000
-65% -$38M 2.35% 11
2014
Q2 		$58M Buy
260,000
+47,500
+22% +$9.83M 4.93% 4
2014
Q1 		$43.7M Buy
+212,500
New +$42.1M 4.36% 4
2013
Q4 		– Sell
-48,858
Closed -$7.04M – 136
2013
Q3 		$7.04M Buy
+48,858
New +$6.51M 0.58% 53

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Alydar Partners's AGN Position: Q1 2015 in Review

Alydar Partners reduced its Allergan plc (AGN) stake by 80% in Q1 2015, selling an estimated $24.2M and leaving 21,000 shares worth $6.25M. The position accounts for 3.39% of the portfolio, ranked #6.

Alydar Partners first reported a position in AGN in Q3 2013 and has held it in 6 quarters since. The position peaked at $58M in Q2 2014. 1,089 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Alydar Partners held 21,000 shares of Allergan plc worth $6.25M as of Q1 2015.
  • Alydar Partners sold 84,947 Allergan plc shares in Q1 2015, an estimated $24.2M.
  • Allergan plc made up 3.39% of Alydar Partners's portfolio in Q1 2015, its #6 holding.
  • Alydar Partners first reported a position in Allergan plc in Q3 2013 and has held it in 6 quarters since.
  • Alydar Partners's Allergan plc position peaked at $58M in Q2 2014.
  • 1,089 funds tracked by Wall St. Rank held Allergan plc as of Q1 2015.

Based on Alydar Partners's 13F filing for Q1 2015, filed 15 May 2015.